APA (7th ed.) Citation

Tunbridge, M., Perkins, G. B., Singer, J., Salehi, T., Ying, T., Grubor-Bauk, B., . . . Coates, P. T. (2022). Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: Study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients. Trials, 23(1), 1. https://doi.org/10.1186/s13063-022-06634-w

Chicago Style (17th ed.) Citation

Tunbridge, Matthew, et al. "Rapamycin and Inulin for Booster Vaccine Response Stimulation (RIVASTIM)—rapamycin: Study Protocol for a Randomised, Controlled Trial of Immunosuppression Modification with Rapamycin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-022-06634-w.

MLA (9th ed.) Citation

Tunbridge, Matthew, et al. "Rapamycin and Inulin for Booster Vaccine Response Stimulation (RIVASTIM)—rapamycin: Study Protocol for a Randomised, Controlled Trial of Immunosuppression Modification with Rapamycin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-022-06634-w.